ID 5HT3D_HUMAN Reviewed; 454 AA. AC Q70Z44; C9J2I6; J3QT78; Q495N5; Q495N6; Q7Z6B3; DT 04-DEC-2007, integrated into UniProtKB/Swiss-Prot. DT 28-JUN-2011, sequence version 3. DT 27-MAR-2024, entry version 165. DE RecName: Full=5-hydroxytryptamine receptor 3D {ECO:0000305|PubMed:17392525}; DE Short=5-HT3-D; DE Short=5-HT3D; DE AltName: Full=Serotonin receptor 3D; DE Flags: Precursor; GN Name=HTR3D {ECO:0000312|HGNC:HGNC:24004}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RX PubMed=12801637; DOI=10.1016/s0378-1119(03)00503-1; RA Niesler B., Frank B., Kapeller J., Rappold G.A.; RT "Cloning, physical mapping and expression analysis of the human 5-HT3 RT serotonin receptor-like genes HTR3C, HTR3D and HTR3E."; RL Gene 310:101-111(2003). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, TRANSPORTER ACTIVITY, RP SUBUNIT, SUBCELLULAR LOCATION, AND VARIANT GLY-171. RX PubMed=17392525; DOI=10.1124/mol.106.032144; RA Niesler B., Walstab J., Combrink S., Moeller D., Kapeller J., Rietdorf J., RA Boenisch H., Goethert M., Rappold G., Bruess M.; RT "Characterization of the novel human serotonin receptor subunits 5-HT3C, 5- RT HT3D, and 5-HT3E."; RL Mol. Pharmacol. 72:8-17(2007). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16641997; DOI=10.1038/nature04728; RA Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., RA Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., RA Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., RA Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., RA Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., RA Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., RA Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., RA Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., RA Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., RA Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., RA Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., RA Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., RA Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., RA Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., RA Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., RA Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., RA Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., RA Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.; RT "The DNA sequence, annotation and analysis of human chromosome 3."; RL Nature 440:1194-1198(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANTS RP HIS-225 AND HIS-435. RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Forms serotonin (5-hydroxytryptamine/5-HT3)-activated cation- CC selective channel complexes, which when activated cause fast, CC depolarizing responses in neurons. {ECO:0000269|PubMed:17392525}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963, CC ChEBI:CHEBI:29101; Evidence={ECO:0000250|UniProtKB:P46098}; CC -!- CATALYTIC ACTIVITY: CC Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103; CC Evidence={ECO:0000250|UniProtKB:P46098}; CC -!- CATALYTIC ACTIVITY: CC Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671, CC ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:17392525}; CC -!- SUBUNIT: Forms homopentameric as well as heteropentameric serotonin- CC activated cation-selective channel complexes with HTR3A. The homomeric CC complex is not functional. Heteropentameric complexes display CC properties which resemble that of neuronal serotonin-activated channels CC in vivo. {ECO:0000269|PubMed:17392525}. CC -!- INTERACTION: CC Q70Z44; P46098: HTR3A; NbExp=5; IntAct=EBI-9008717, EBI-9008743; CC -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane CC {ECO:0000305|PubMed:17392525}; Multi-pass membrane protein CC {ECO:0000255}. Cell membrane {ECO:0000269|PubMed:17392525}; Multi-pass CC membrane protein {ECO:0000255}. Note=Presumably retained within the CC endoplasmic reticulum unless complexed with HTR3A. CC {ECO:0000269|PubMed:17392525}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=4; CC Name=1; CC IsoId=Q70Z44-1; Sequence=Displayed; CC Name=2; CC IsoId=Q70Z44-2; Sequence=VSP_029798, VSP_029799, VSP_029801; CC Name=3; CC IsoId=Q70Z44-3; Sequence=VSP_029797, VSP_029800, VSP_029801; CC Name=4; CC IsoId=Q70Z44-4; Sequence=VSP_044828, VSP_044829, VSP_044830, CC VSP_029801; CC -!- TISSUE SPECIFICITY: Expressed in liver, as well as fetal and adult CC colon and kidney. {ECO:0000269|PubMed:12801637}. CC -!- DOMAIN: The HA-stretch region of HTR3D seems to confer increased CC conductance to HTR3A/HTR3D heteropentamers compared to that of HTR3A CC homopentamers. {ECO:0000250|UniProtKB:O95264}. CC -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family. CC 5-hydroxytryptamine receptor (TC 1.A.9.2) subfamily. HTR3D sub- CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ437318; CAD24817.1; -; mRNA. DR EMBL; AY159812; AAO38166.2; -; mRNA. DR EMBL; AC068644; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC131235; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC101090; AAI01091.1; -; mRNA. DR EMBL; BC101091; AAI01092.1; -; mRNA. DR CCDS; CCDS3249.1; -. [Q70Z44-2] DR CCDS; CCDS46966.1; -. [Q70Z44-4] DR CCDS; CCDS54685.1; -. [Q70Z44-1] DR CCDS; CCDS93429.1; -. [Q70Z44-3] DR RefSeq; NP_001138615.1; NM_001145143.1. [Q70Z44-4] DR RefSeq; NP_001157118.1; NM_001163646.1. [Q70Z44-1] DR RefSeq; NP_872343.2; NM_182537.2. DR RefSeq; XP_016861343.1; XM_017005854.1. DR AlphaFoldDB; Q70Z44; -. DR BioGRID; 128355; 11. DR ComplexPortal; CPX-272; 5-hydroxytryptamine-3A/D receptor complex. DR IntAct; Q70Z44; 4. DR STRING; 9606.ENSP00000371929; -. DR BindingDB; Q70Z44; -. DR ChEMBL; CHEMBL2094132; -. DR DrugBank; DB01239; Chlorprothixene. DR DrugBank; DB11273; Dihydroergocornine. DR DrugBank; DB13345; Dihydroergocristine. DR DrugBank; DB01049; Ergoloid mesylate. DR DrugBank; DB00898; Ethanol. DR DrugBank; DB12141; Gilteritinib. DR DrugBank; DB00715; Paroxetine. DR DrugBank; DB09304; Setiptiline. DR DrugBank; DB13025; Tiapride. DR DrugBank; DB00246; Ziprasidone. DR DrugCentral; Q70Z44; -. DR TCDB; 1.A.9.2.3; the neurotransmitter receptor, cys loop, ligand-gated ion channel (lic) family. DR GlyCosmos; Q70Z44; 1 site, No reported glycans. DR GlyGen; Q70Z44; 1 site. DR iPTMnet; Q70Z44; -. DR PhosphoSitePlus; Q70Z44; -. DR BioMuta; HTR3D; -. DR DMDM; 338817899; -. DR jPOST; Q70Z44; -. DR MassIVE; Q70Z44; -. DR PaxDb; 9606-ENSP00000371929; -. DR PeptideAtlas; Q70Z44; -. DR ProteomicsDB; 68580; -. [Q70Z44-1] DR Antibodypedia; 56799; 68 antibodies from 14 providers. DR DNASU; 200909; -. DR Ensembl; ENST00000382489.3; ENSP00000371929.3; ENSG00000186090.11. [Q70Z44-1] DR Ensembl; ENST00000428798.7; ENSP00000405409.2; ENSG00000186090.11. [Q70Z44-4] DR Ensembl; ENST00000453435.1; ENSP00000389268.1; ENSG00000186090.11. [Q70Z44-3] DR GeneID; 200909; -. DR KEGG; hsa:200909; -. DR MANE-Select; ENST00000428798.7; ENSP00000405409.2; NM_001145143.1; NP_001138615.1. [Q70Z44-4] DR UCSC; uc010hxp.4; human. [Q70Z44-1] DR AGR; HGNC:24004; -. DR CTD; 200909; -. DR DisGeNET; 200909; -. DR GeneCards; HTR3D; -. DR HGNC; HGNC:24004; HTR3D. DR HPA; ENSG00000186090; Not detected. DR MIM; 610122; gene. DR neXtProt; NX_Q70Z44; -. DR OpenTargets; ENSG00000186090; -. DR PharmGKB; PA134866755; -. DR VEuPathDB; HostDB:ENSG00000186090; -. DR eggNOG; KOG3645; Eukaryota. DR GeneTree; ENSGT00940000156739; -. DR HOGENOM; CLU_018074_5_2_1; -. DR InParanoid; Q70Z44; -. DR OMA; WKCAGIT; -. DR OrthoDB; 5489962at2759; -. DR PhylomeDB; Q70Z44; -. DR TreeFam; TF315605; -. DR PathwayCommons; Q70Z44; -. DR Reactome; R-HSA-112314; Neurotransmitter receptors and postsynaptic signal transmission. DR SignaLink; Q70Z44; -. DR SIGNOR; Q70Z44; -. DR BioGRID-ORCS; 200909; 15 hits in 1140 CRISPR screens. DR ChiTaRS; HTR3D; human. DR GeneWiki; HTR3D; -. DR GenomeRNAi; 200909; -. DR Pharos; Q70Z44; Tchem. DR PRO; PR:Q70Z44; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q70Z44; Protein. DR Bgee; ENSG00000186090; Expressed in primordial germ cell in gonad and 2 other cell types or tissues. DR ExpressionAtlas; Q70Z44; baseline and differential. DR GO; GO:0043005; C:neuron projection; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0045211; C:postsynaptic membrane; IEA:UniProtKB-SubCell. DR GO; GO:1904602; C:serotonin-activated cation-selective channel complex; IPI:ComplexPortal. DR GO; GO:0045202; C:synapse; IBA:GO_Central. DR GO; GO:0022848; F:acetylcholine-gated monoatomic cation-selective channel activity; IBA:GO_Central. DR GO; GO:0022850; F:serotonin-gated monoatomic cation channel activity; IDA:CACAO. DR GO; GO:0098662; P:inorganic cation transmembrane transport; IDA:ComplexPortal. DR GO; GO:0007210; P:serotonin receptor signaling pathway; IDA:ComplexPortal. DR CDD; cd19063; LGIC_TM_5-HT3; 1. DR Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1. DR Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 1. DR InterPro; IPR006202; Neur_chan_lig-bd. DR InterPro; IPR036734; Neur_chan_lig-bd_sf. DR InterPro; IPR006201; Neur_channel. DR InterPro; IPR036719; Neuro-gated_channel_TM_sf. DR InterPro; IPR038050; Neuro_actylchol_rec. DR InterPro; IPR006029; Neurotrans-gated_channel_TM. DR PANTHER; PTHR18945:SF409; 5-HYDROXYTRYPTAMINE RECEPTOR 3D; 1. DR PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1. DR Pfam; PF02931; Neur_chan_LBD; 1. DR Pfam; PF02932; Neur_chan_memb; 1. DR SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1. DR SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1. PE 1: Evidence at protein level; KW Alternative splicing; Cell membrane; Glycoprotein; Ion channel; KW Ion transport; Ligand-gated ion channel; Membrane; KW Postsynaptic cell membrane; Receptor; Reference proteome; Signal; Synapse; KW Transmembrane; Transmembrane helix; Transport. FT SIGNAL 1..24 FT /evidence="ECO:0000255" FT CHAIN 25..454 FT /note="5-hydroxytryptamine receptor 3D" FT /id="PRO_0000312293" FT TOPO_DOM 25..232 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 233..253 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 254..264 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 265..285 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 286..306 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 307..327 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 328..431 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 432..452 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 453..454 FT /note="Extracellular" FT /evidence="ECO:0000255" FT REGION 363..410 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 399..430 FT /note="HA-stretch; determines single-channel conductance in FT 5-HT3 receptors" FT /evidence="ECO:0000250|UniProtKB:P46098" FT CARBOHYD 66 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1..219 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029797" FT VAR_SEQ 1..135 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17392525" FT /id="VSP_029798" FT VAR_SEQ 1..37 FT /note="MQKHSPGPPALALLSQSLLTTGNGDTLIINCPGFGQH -> MERGWFHGKGF FT LLGFILHLLLQDSHLQLVTSFLWLNM (in isoform 4)" FT /evidence="ECO:0000305" FT /id="VSP_044828" FT VAR_SEQ 38..98 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000305" FT /id="VSP_044829" FT VAR_SEQ 171 FT /note="A -> GERSPSALSPTQVT (in isoform 4)" FT /evidence="ECO:0000305" FT /id="VSP_044830" FT VAR_SEQ 172..220 FT /note="RAWRRMSRSFQIHHRTSFRTRREWVLLGIQKRTIKVTVATNQYEQAIFH -> FT ERSPSALSPTQ (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17392525" FT /id="VSP_029799" FT VAR_SEQ 220 FT /note="H -> M (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_029800" FT VAR_SEQ 295..306 FT /note="APLALMQTPLPA -> RPHPSRDQKR (in isoform 2, isoform 3 FT and isoform 4)" FT /evidence="ECO:0000303|PubMed:15489334, FT ECO:0000303|PubMed:17392525" FT /id="VSP_029801" FT VARIANT 171 FT /note="A -> G (in dbSNP:rs6443930)" FT /evidence="ECO:0000269|PubMed:17392525" FT /id="VAR_037478" FT VARIANT 225 FT /note="R -> H (in dbSNP:rs1000952)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_037479" FT VARIANT 435 FT /note="R -> H (in dbSNP:rs6789754)" FT /evidence="ECO:0000269|PubMed:15489334" FT /id="VAR_037480" FT CONFLICT 155 FT /note="S -> P (in Ref. 4; AAI01092)" FT /evidence="ECO:0000305" FT CONFLICT 368 FT /note="K -> R (in Ref. 2; AAO38166)" FT /evidence="ECO:0000305" SQ SEQUENCE 454 AA; 50191 MW; 8B12F6CC31C4446C CRC64; MQKHSPGPPA LALLSQSLLT TGNGDTLIIN CPGFGQHRVD PAAFQAVFDR KAIGPVTNYS VATHVNISFT LSAIWNCYSR IHTFNCHHAR PWHNQFVQWN PDECGGIKKS GMATENLWLS DVFIEESVDQ TPAGLMASMS IVKATSNTIS QCGWSASANW TPSISPSMDR ARAWRRMSRS FQIHHRTSFR TRREWVLLGI QKRTIKVTVA TNQYEQAIFH VAIRRRCRPS PYVVNFLVPS GILIAIDALS FYLPLESGNC APFKMTVLLG YSVFLLMMND LLPATSTSSH ASLVAPLALM QTPLPAGVYF ALCLSLMVGS LLETIFITHL LHVATTQPLP LPRWLHSLLL HCTGQGRCCP TAPQKGNKGP GLTPTHLPGV KEPEVSAGQM PGPGEAELTG GSEWTRAQRE HEAQKQHSVE LWVQFSHAMD ALLFRLYLLF MASSIITVIC LWNT //